trending Market Intelligence /marketintelligence/en/news-insights/trending/NVvyGVyb_cVuJUMIVrf9CA2 content esgSubNav
In This List

Neovasc raises $11.5M in stock, debt offerings

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Neovasc raises $11.5M in stock, debt offerings

Neovasc Inc. closed a private placement of common shares to raise about $1.7 million in gross proceeds.

The Richmond, British Columbia-based company sold 3,349,514 common shares in the placement at 51.5 cents apiece. Separately, the company issued a debenture for gross proceeds of $9.8 million.

Neovasc, which develops, manufactures and markets medical devices worldwide, plans to use the proceeds — $11.5 million in total — for the development and commercialization of the Neovasc Reducer stent.

Funds raised will also be used for the development of Neovasc's transcatheter device, Tiara, along with general corporate and working capital purposes.